E-Folder
#1 in Business Subscribe Email Print

You are here: Home > Business > Workplace Communication > Relevance of Medical Metaphor in Corporate Turnaround

Tags

  • biological
  • healthy
  • pharmaceutical
  • companies involved
  • medical metaphors
  • companies involved

  • Links

  • HECM Reverse Mortgages - How Much Money Can You Get?
  • Encouraging the Elderly to Journal: It's Never Too Late
  • Affordable Family Health Insurance
  • E-Folder - Relevance of Medical Metaphor in Corporate Turnaround

    Medical metaphors are applicable in corporate as people can comprehend their medical and health conditions much better than corporate matters.

    Metaphor is a comp
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    arative figure of speech in which a term is transferred from the object it ordinarily designates to an object it may designate only by implicit comparison or
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    nalogy. It is a comparison of something familiar to something unfamiliar and used in this book to explain a common “corporate wellness” principle. It is an effe
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    tive way for people to create meaning by using one element of experience to understand another. Or to use an analogy, metaphor is like a bridge, it spans the
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    gap between what the turnaround manager wants the sick company to know and what the sick company already knows.

    Metaphor gives us the opportunity to stretch ou
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    imagination, create powerful insights and deepen our understanding, thereby allowing us to see and act in new ways. Such medical metaphors couched into princ
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    ples serve to enable the executives to draw parallels to their corporate issues and facilitate their diagnosis and remedies.

    There are many similarities betwee
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    n a company and a person. Just like a human being, a company can get ill. Many companies are falling sick due to a whole host of factors such as the economic
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    lowdown, competition and incompetent management. Sickness is a big business but nobody wants to be the patient or remain as the patient. Corporate ill health
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    s also a big business, as in a declining and stagnant economy, there are more sick companies than healthy ones. Every company and individual wants to be in the
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ink of health.

    It is important to keep your body healthy and well. Doctors generally only treat the disease and do not treat wellness. Individuals are beginn
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    ing to recognize the importance of wellness which is becoming a big business. The pharmaceutical industry understands this as the drugs consumed for surgery a
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    d treatment are only for temporary demand. Whereas, the drugs consumed for healing and wellness are for the longer term. This is why medicines such as cholest
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    rol lowering drugs, anti-depressant drugs and health supplements are in great demand. It is small wonder that there is such an enormous research on the Intern
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    et on health matters. Hence the growing trend is for companies to target wellness as a business.

    Similarly, we will see an increased awareness for companies to
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    target for corporate wellness. After decades of downsizing and delayering, companies have found that the state of health has not significantly improved. Moral
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    and loyalty of the staff have deteriorated and companies are caught in a vicious cycle of restructuring to stay competitive. Companies have found that it is
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    better for them to stay well and healthy, as one does not have to get sick to get better.

    There are workable preventive, diagnostic and therapeutic steps to tr
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    at sick companies, and to restore as well as maintain their well being. Similar to handling of a person’s health, a company needs to monitor the five stages t
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    sustain long-term health and wellness, namely, prevention, early diagnosis, proper treatment, recovery or rehabilitation and strengthening or health-boosting


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.e-folder.org.ua/article/46976/e-folder-Relevance-of-Medical-Metaphor-in-Corporate-Turnaround.html">Relevance of Medical Metaphor in Corporate Turnaround</a>

    BB link (for phorums):
    [url=http://www.e-folder.org.ua/article/46976/e-folder-Relevance-of-Medical-Metaphor-in-Corporate-Turnaround.html]Relevance of Medical Metaphor in Corporate Turnaround[/url]

    Related Articles:

    Customer Service and Just in Time Distribution Conflicts

    Never Make Another Cold Call Again

    Positional Authority

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com